Florence Anthony A. Jr.'s Form 4 filing
Enliven Therapeutics, Inc. (ELVN) · filed Dec 29, 2021
- Accession no.
- 0001209191-21-071531
- Filed
- Dec 29, 2021, 6:35 PM ET
- Trade date
- Dec 27-29, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $159.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Florence Anthony A. Jr.CIK 0001559827 | Director, 10% Owner |
| Kerins Patrick JCIK 0001235112 | 10% Owner |
| Sandell Scott DCIK 0001237289 | 10% Owner |
| Baskett ForestCIK 0001277631 | 10% Owner |
| New Enterprise Associates 14, L.P.CIK 0001544328 | 10% Owner |
| NEA Partners 14, L.P.CIK 0001551531 | 10% Owner |
| Nea 14 GP, LtdCIK 0001551532 | 10% Owner |
| Sonsini Peter W.CIK 0001559807 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2021 | Common Stock | SSaleDisposed | −27,651 | $2.42 | −$67,006.67 | 3,695,192 | Direct | |
| Dec 28, 2021 | Common Stock | SSaleDisposed | −24,580 | $2.34 | −$57,539.32 | 3,670,612 | Direct | |
| Dec 29, 2021 | Common Stock | SSaleDisposed | −15,196 | $2.30 | −$34,953.84 | 3,655,416 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.